Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Covington
Dow
Fish and Richardson
Baxter
Merck
UBS
Cipla
Mallinckrodt

Generated: December 16, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: RALOXIFENE HYDROCHLORIDE

« Back to Dashboard

RALOXIFENE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA Eli Lilly and Company 0002-4184-02 100 TABLET in 1 BOTTLE (0002-4184-02)
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA Eli Lilly and Company 0002-4184-07 1 BOTTLE in 1 CARTON (0002-4184-07) > 2000 TABLET in 1 BOTTLE
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA Eli Lilly and Company 0002-4184-30 30 TABLET in 1 BOTTLE (0002-4184-30)
Lilly EVISTA raloxifene hydrochloride TABLET;ORAL 020815 NDA AUTHORIZED GENERIC KAISER FOUNDATION HOSPITALS 0179-0151-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-0151-70)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Medtronic
McKesson
McKinsey
UBS
Argus Health
Federal Trade Commission
AstraZeneca